Present treatments for dementia are largely palliative, providing symptomatic but temporary improvement. In contrast, agents that promise disease modification offer the hope of prevention, arrest, or deceleration of decline. However, enthusiasm for these new agents must be tempered by acknowledgment of their inevitable limitations within the present standard dementia care.
|Original language||English (US)|
|Number of pages||5|
|Publication status||Published - Nov 1 2007|
ASJC Scopus subject areas
- Psychiatry and Mental health